athagoras has acquired DiaMed Beratungsgesellschaft für pharmazeutische Unternehmen mbH, enhancing its Regulatory Affairs and Pharmacovigilance capabilities in the German Life Sciences market.

Target Overview

athagoras has successfully acquired DiaMed Beratungsgesellschaft für pharmazeutische Unternehmen mbH, a distinguished consultancy based in Germany specializing in Regulatory Affairs (RA) and Pharmacovigilance (PV). Established in 1992 by Dr. Johannes Kremer, DiaMed has earned a reputation as a trusted partner for pharmaceutical companies, providing critical guidance throughout their regulatory and post-marketing endeavors. This acquisition represents a strategic move for athagoras, enhancing its expertise and solidifying its presence in Germany, a pivotal market within the European Life Sciences sector.

By incorporating DiaMed into its operations, athagoras is poised to augment its existing capabilities in RA and PV. The integration will not only deepen its scientific knowledge but also increase local capacity, enabling the provision of scalable, high-quality support for clients throughout the product lifecycle. With DiaMed's team boasting decades of hands-on experience in regulatory strategy, compliance, and drug safety, this partnership promises to enhance athagoras' operations, particularly those of its subsidiaries, CSO Pharma and S-Cube, which are part of the PV cluster.

Industry Overview in Germany

The Life Sciences sector in Germany is recognized for its innovative contributions to healthcare, bolstered by a robust regulatory framework and a proactive stance on public health. The country is home to numerous pharmaceutic